Vaxart (NASDAQ: VXRT) reported Q2 EPS of ($0.06), $0.03 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $27.19 million versus the consensus estimate of $50.5 million.

For earnings history and earnings-related data on Vaxart (VXRT) click here.